ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2048

Four Physician Global Assessments for Overall Status, Inflammation, Damage, and Unexplained Symptoms Are Useful in Usual Care of Patients with Osteoarthritis, Fibromyalgia, Systemic Lupus Erythematosus, and Spondyloarthropathy, As Well As Rheumatoid Arthritis

Isabel Castrejón1, Martin J. Bergman2 and Theodore Pincus1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Taylor Hospital, Ridley Park, PA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Assessment, fibromyalgia, Inflammation, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Quality Measures and Innovations in Practice Management and Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose: A physician global estimate (DOCGL) is important in clinical decisions concerning patients with rheumatoid arthritis (RA), and often is the most efficient of the 7 RA Core Data Set measures to distinguish active from control treatments in RA clinical trials. DOCGL is designed to assess inflammatory activity, but may be influenced by organ damage and “unexplained” chronic pain syndromes. Therefore, 3 subscale DOCGL visual analog scales (VAS) have been developed to estimate level of a) inflammation, b) damage, and c) “unexplained symptoms,” in addition to overall status, reflecting the expertise of the rheumatologist concerning whether patient symptoms result primarily from one of these 3 bases. We analyzed the 4 DOCGL estimates for inflammation, damage, “unexplained” and overall status in consecutive patients with 5 rheumatic diagnoses: RA, osteoarthritis (OA), fibromyalgia (FM), systemic lupus erythematosus (SLE), and spondyloarthropathy (SpA).

Methods: The study was conducted in the private practice of one rheumatologist. All consecutive patients, regardless of diagnosis, complete a patient questionnaire, and are assigned four DOCGL estimates: overall status, inflammation, damage to any organ (e.g., joint, kidney) and “unexplained symptoms.” Overall DOCGL was scored 0-10; the other 3 scales were scored 0-3 and recoded to 0-10, the current practice. Physician estimates at first visit of consecutive patients for the 4 DOCGL scales were analyzed in 5 diagnostic categories: RA (n=39), OA (n=41), FM (n=15), SLE (n=14) and SpA (n=23). Mean (standard deviation) and Spearman correlations were computed for overall physician global estimate with subscale estimates for inflammation, damage and “unexplained,” as well as patient global estimate of status.

Results: DOCGL for overall status ranged from 2.6 to 5.0, highest for patients with FM (5.0), followed by RA (3.9), SpA (3.9), OA (3.6), and SLE (2.6). Physician subscale estimates were higher for inflammation than for damage or “unexplained” in RA, SLE, and SpA; higher for damage than for inflammation or “unexplained” in OA; and higher for “unexplained” than for inflammation or damage in FM (Table). Highest correlations of overall DOCGL were seen with physician subscale estimates for inflammation in RA, SLE, and SpA; with damage in OA; and with “unexplained” in FM.

Conclusion: Physician estimates for inflammation, damage and “unexplained symptoms” differ in patients with different rheumatic diagnoses. These 3 subscales reflect the expertise of the rheumatologist to estimate the basis for patient symptoms, and supplement the overall physician global estimate as a quantitative summary of the physical examination to assess and monitor patients with all rheumatic diseases in usual care.


Disclosure:

I. Castrejón,
None;

M. J. Bergman,
None;

T. Pincus,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/four-physician-global-assessments-for-overall-status-inflammation-damage-and-unexplained-symptoms-are-useful-in-usual-care-of-patients-with-osteoarthritis-fibromyalgia-systemic-lupus-erythematosu/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology